Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Keratin 75 is important for fast wound healing and works with SOX2 and the LINC complex to help skin cells move and repair damage.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Glucosylceramides are essential for healthy skin and proper wound healing.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Fatp4 is crucial for healthy skin development and function.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.